These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12184028)

  • 21. [Effect of shenshuaining dispersible tablets on the levels of NO, NOS, SOD and MDA in kidney of chronic renal failure rats].
    Chen Y; Xiao W; Ma Y; Hou LB
    Zhong Yao Cai; 2008 Aug; 31(8):1190-3. PubMed ID: 19112899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic role of arjunolic acid in response to streptozotocin mediated diabetic renal injury: activation of polyol pathway and oxidative stress responsive signaling cascades.
    Manna P; Sinha M; Sil PC
    Chem Biol Interact; 2009 Oct; 181(3):297-308. PubMed ID: 19682444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propofol reduces nitric oxide biosynthesis in lipopolysaccharide-activated macrophages by downregulating the expression of inducible nitric oxide synthase.
    Chen RM; Wu GJ; Tai YT; Sun WZ; Lin YL; Jean WC; Chen TL
    Arch Toxicol; 2003 Jul; 77(7):418-23. PubMed ID: 12851743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB.
    Chiu J; Khan ZA; Farhangkhoee H; Chakrabarti S
    Nutrition; 2009 Sep; 25(9):964-72. PubMed ID: 19268536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early anemia in diabetic nephropathy].
    Nagy J; Kiss I; Wittmann I
    Orv Hetil; 2005 Feb; 146(9):397-401. PubMed ID: 15830606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
    Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of free radicals and reactive nitrogen species in the late complications of diabetes mellitus in rats].
    Stadler K; Jenei V; von Bölcsházy G; Somogyi A; Jakus J
    Orv Hetil; 2004 May; 145(21):1135-40. PubMed ID: 15206194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does nitric oxide, an inflammatory mediator of glomerular mesangial cells, have a role in diabetic nephropathy?
    Pfeilschifter J
    Kidney Int Suppl; 1995 Sep; 51():S50-60. PubMed ID: 7474691
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathogenic role of nitric oxide alterations in diabetic nephropathy.
    Prabhakar SS
    Curr Diab Rep; 2005 Dec; 5(6):449-54. PubMed ID: 16316597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperfiltration, nitric oxide, and diabetic nephropathy.
    Levine DZ
    Curr Hypertens Rep; 2006 May; 8(2):153-7. PubMed ID: 16672149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular aspects of toxic effects of nitric oxide].
    Stepnik M
    Med Pr; 2001; 52(5):375-81. PubMed ID: 11828853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide and kidney oxygenation.
    Palm F; Teerlink T; Hansell P
    Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):68-73. PubMed ID: 19077692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interactions of nitric oxide with oxygen radicals and scavengers in cerebral ischemic injury.
    Beckman JS; Ye YZ; Chen J; Conger KA
    Adv Neurol; 1996; 71():339-50; discussion 350-4. PubMed ID: 8790810
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy.
    Leon CA; Raij L
    J Hypertens; 2005 Nov; 23(11):1931-7. PubMed ID: 16208129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactive oxygen species and endothelins in diabetic nephropathy.
    Kohan DE
    J Lab Clin Med; 2000 Apr; 135(4):300-2. PubMed ID: 10779044
    [No Abstract]   [Full Text] [Related]  

  • 36. Assays for nitric oxide expression.
    Stone WL; Yang H; Qui M
    Methods Mol Biol; 2006; 315():245-56. PubMed ID: 16110163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. To: Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC (2003) Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46:426-428.
    Ng DP; Warram JH; Krolewski AS
    Diabetologia; 2003 Dec; 46(12):1706. PubMed ID: 14595537
    [No Abstract]   [Full Text] [Related]  

  • 38. The possible role of glutathione-S-transferase activity in diabetic nephropathy.
    Tesauro M; Nisticò S; Noce A; Tarantino A; Marrone G; Costa A; Rovella V; Di Cola G; Campia U; Lauro D; Cardillo C; Di Daniele N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):129-33. PubMed ID: 25816416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of nitric oxide in the physiology and pathophysiology of the exocrine pancreas.
    Hegyi P; Rakonczay Z
    Antioxid Redox Signal; 2011 Nov; 15(10):2723-41. PubMed ID: 21777142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide and tissue destruction.
    Kendall HK; Marshall RI; Bartold PM
    Oral Dis; 2001 Jan; 7(1):2-10. PubMed ID: 11354916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.